Menu

Blog

Sep 25, 2023

Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval

Posted by in categories: biotech/medical, neuroscience

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.

The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.

“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.”


A study has found that the psychedelic drug MDMA, combined with talk therapy, can reduce symptoms of post-traumatic stress disorder.

Comments are closed.